GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » Cyclically Adjusted Price-to-FCF

Avax Technologies (Avax Technologies) Cyclically Adjusted Price-to-FCF : (As of Jun. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Avax Technologies Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Avax Technologies Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Avax Technologies's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies Cyclically Adjusted Price-to-FCF Chart

Avax Technologies Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avax Technologies Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avax Technologies's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Avax Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avax Technologies's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avax Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Avax Technologies's Cyclically Adjusted Price-to-FCF falls into.



Avax Technologies Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Avax Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2008 is calculated as:

For example, Avax Technologies's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2008 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2008 (Change)*Current CPI (Sep. 2008)
=-0.007/92.3069*92.3069
=-0.007

Current CPI (Sep. 2008) = 92.3069.

Avax Technologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
199812 -0.158 69.151 -0.211
199903 -0.250 69.615 -0.331
199906 -0.218 70.122 -0.287
199909 -0.184 70.839 -0.240
199912 -0.235 71.008 -0.305
200003 -0.137 72.231 -0.175
200006 -0.169 72.737 -0.214
200009 -0.183 73.286 -0.230
200012 -0.196 73.413 -0.246
200103 -0.233 74.341 -0.289
200106 -0.141 75.100 -0.173
200109 -0.142 75.227 -0.174
200112 -0.142 74.552 -0.176
200203 -0.160 75.438 -0.196
200206 -0.162 75.902 -0.197
200209 -0.119 76.366 -0.144
200212 -0.115 76.324 -0.139
200303 -0.140 77.716 -0.166
200306 -0.035 77.505 -0.042
200309 -0.016 78.138 -0.019
200312 -0.022 77.758 -0.026
200403 -0.028 79.066 -0.033
200406 -0.026 80.037 -0.030
200409 -0.025 80.121 -0.029
200412 -0.019 80.290 -0.022
200503 -0.014 81.555 -0.016
200506 -0.017 82.062 -0.019
200509 -0.021 83.876 -0.023
200512 -0.019 83.032 -0.021
200603 -0.016 84.298 -0.018
200606 -0.017 85.606 -0.018
200609 -0.018 85.606 -0.019
200612 -0.016 85.142 -0.017
200703 -0.009 86.640 -0.010
200706 -0.010 87.906 -0.011
200709 -0.009 87.964 -0.009
200712 -0.012 88.616 -0.012
200803 -0.019 90.090 -0.019
200806 -0.013 92.320 -0.013
200809 -0.007 92.307 -0.007

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avax Technologies  (OTCPK:AVXT) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Avax Technologies Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Avax Technologies's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Avax Technologies (Avax Technologies) Business Description

Traded in Other Exchanges
N/A
Address
9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210
Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.
Executives
Carl Spana director PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A director ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines